Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Adjuvant Pain Control Following Acute Rib Fractures
NCT02856750Phase 1Completed
- Sponsor
- Denver Health
- Start
- Oct 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in acute pain comparing Gabapentin with Placebo (2 arms). Primary endpoint: Average Daily Pain Score at 30 days. Started Oct 2016; status: completed.
02
Drugs
gabapentin
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT02856750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856750.